KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVS) Assets Average (2016 - 2025)

Historic Assets Average for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $109.1 billion.

  • Novartis Ag's Assets Average rose 605.92% to $109.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $109.1 billion, marking a year-over-year increase of 605.92%. This contributed to the annual value of $106.6 billion for FY2025, which is 544.24% up from last year.
  • Per Novartis Ag's latest filing, its Assets Average stood at $109.1 billion for Q4 2025, which was up 605.92% from $105.8 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Assets Average registered a high of $128.5 billion during Q1 2022, and its lowest value of $95.9 billion during Q2 2024.
  • Over the past 5 years, Novartis Ag's median Assets Average value was $111.7 billion (recorded in 2023), while the average stood at $112.4 billion.
  • Its Assets Average has fluctuated over the past 5 years, first tumbled by 1541.83% in 2024, then skyrocketed by 651.43% in 2025.
  • Over the past 5 years, Novartis Ag's Assets Average (Quarter) stood at $126.5 billion in 2021, then dropped by 6.75% to $118.0 billion in 2022, then dropped by 9.87% to $106.3 billion in 2023, then dropped by 3.23% to $102.9 billion in 2024, then grew by 6.06% to $109.1 billion in 2025.
  • Its Assets Average stands at $109.1 billion for Q4 2025, versus $105.8 billion for Q3 2025 and $102.2 billion for Q2 2025.